LEADER 02297nam 2200385 450 001 9910830930803321 005 20231006191628.0 010 $a3-527-61161-4 035 $a(CKB)4100000000641156 035 $a(NjHacI)994100000000641156 035 $a(EXLCZ)994100000000641156 100 $a20231006d2008 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aHandbook of Tuberculosis /$fStefan H. E. Kaufmann [and three others] 210 1$a[Place of publication not identified] :$cJohn Wiley & Sons, Inc.,$d2008. 215 $a1 online resource (339 pages) 311 $a3-527-31683-3 327 $aV. 1. Molecular biology and biochemistry / edited by Stefan H.E. Kaufmann and Eric Rubin -- v. 2. Immunology and cell biology / edited by Stefan H.E. Kaufmann and Warwick J. Britton -- v. 3. Clinics, diagnostics, therapy, and epidemiology / edited by Stefan H.E. Kaufmann and Paul van Helden --. 330 $aCoinciding with the first TB therapies to enter clinical trials in 60 years, this is the most comprehensive account of the latest developments in clinical, therapeutic and basic research into the disease, presented by the most prolific of all researchers in the field. Divided into three clearly structured volumes, the first deals with molecular biology and biochemistry of the pathogen, including genetics and genomics, as well as drug design. The second volume covers cell biology, immunology and vaccine development, while the third is devoted to epidemiology and clinical approaches, including drug resistance, veterinary aspects and clinical field trials. With one new infection worldwide every second, this is an essential reference for bacteriologists, immunologists, pathologists and pathophysiologists, molecular and cell biologists, as well as those working in the pharmaceutical industry. 606 $aMycobacterium tuberculosis 606 $aTuberculosis 615 0$aMycobacterium tuberculosis. 615 0$aTuberculosis. 676 $a616.2 700 $aKaufmann$b Stefan H. E.$042605 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910830930803321 996 $aHandbook of Tuberculosis$93982493 997 $aUNINA